SEC Form 4 · accession 0001179110-16-027916
MADRIGAL PHARMACEUTICALS, INC. · MDGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Marc R Schneebaum
Officer — Chief Financial Officer
Period of report
Jul 22, 2016
Accepted (ET)
Jul 26, 2016 · 5:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157601
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 22, 2016 | A | 22,969 | $0.00 | A | 42,277 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $9.45 | Jul 22, 2016 | A | 91,876 | A | Jul 22, 2016 | Jul 22, 2026 | Common Stock | 91,876 | 91,876 | D |
Remarks
Exhibit List: Exhibit 24.1 Power of Attorney